The Lawsuit to Stop the Conspiracy
PharmacyChecker is suing Big Pharma-allied groups to protect consumers’ access to information about more affordable medicine from safe international online pharmacies.
- Complaint of Conspiracy: PharmacyChecker.com LLC v. National Association of Boards of Pharmacy et al (nysd-7:2019-cv-07577)
- Amended Complaint of Conspiracy: PharmacyChecker.com LLC v. National Association of Boards of Pharmacy et al (Civil Action No. 7:19-cv-07577-KMK)
This is a case about a company, PharmacyChecker.com, that, for over 20 years, has provided pharmacy verification services and information that helps consumers identify online pharmacies that sell genuine, safe and affordable prescription medication to treat conditions such as high blood pressure, asthma, and diabetes. For much of that time, Big Pharma has funded organizations and campaigns that misinform the public about online pharmacies, importation, and drug prices. They have sought to discredit PharmacyChecker’s mission to help patients struggling with high prescription drug costs. The case, which has been filed in New York and Oregon against multiple defendants, alleges an unlawful conspiracy to suppress the information that PharmacyChecker provides to the public.
Update 1/9/2024: We are pleased with the recent ruling in the U.S. District Court of Oregon denying a motion filed by a defendant, LegitScipt, LLC, to dismiss the case there. As noted in the ruling, U.S. District Judge Michael H. Simon stated that PharmacyChecker's business is legal and that the defendant failed to identify any federal or state laws that PharmacyChecker violated. PharmacyChecker can now proceed to a jury trial in Oregon to prosecute its antitrust claim against LegitScript.
With the Oregon court agreeing with PharmacyChecker’s positions on key issues of fact and law, PharmacyChecker also plans to appeal the New York district court’s April 2023 decision, which stalled the case against alleged co-conspirators The Alliance for Safe Online Pharmacies, Center for Safe Internet Pharmacies, National Association of Board of Pharmacy and the Partnership for Safe Medicines. We believe such an appeal will allow the New York case to move forward. PharmacyChecker looks forward to continuing its fight for competition and transparency in prescription drug pricing.